Apolipoprotein E Receptor Binding VersusHeparan Sulfate Proteoglycan Binding in Its Regulation of Smooth Muscle Cell Migration and Proliferation
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
This study showed that synthetic peptides containing either a single copy or tandem repeat of the receptor binding domain sequence of apolipoprotein (apo) E, or a peptide containing its C-terminal heparin binding domain, apoE-(211-243), were all effective inhibitors of platelet-derived growth factor (PDGF)-stimulated smooth muscle cell proliferation. In contrast, only the peptide containing a tandem repeating unit of the receptor binding domain sequence of apoE, apoE-(141-155)(2), was capable of inhibiting PDGF-directed smooth muscle cell migration. Peptide containing only a single unit of this sequence, apoE-(141-155), or the apoE-(211-243) peptide were ineffective in inhibiting PDGF-directed smooth muscle cell migration. Additional experiments showed that reductively methylated apoE, which is incapable of receptor binding yet retains its heparin binding capability, was equally effective as apoE in inhibiting PDGF-stimulated smooth muscle cell proliferation. However, reductively methylated apoE was unable to inhibit smooth muscle cell migration toward PDGF. Additionally, the receptor binding domain-specific apoE antibody 1D7 also mitigated the anti-migratory properties of apoE on smooth muscle cells. Finally, pretreatment of cells with heparinase failed to abolish apoE inhibition of smooth muscle cell migration. Taken together, these data documented that apoE inhibition of PDGF-stimulated smooth muscle cell proliferation is mediated by its binding to heparan sulfate proteoglycans, while its inhibition of cell migration is mediated through apoE binding to cell surface receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
Reddick, R. L., Zhang, S. H., & Maeda, N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.141 · Cited by 633
Gotthardt, M., Trommsdorff, M., Nevitt, M. F., Shelton, J., Richardson, J. A., Stockinger, W., Nimpf, J., & Herz, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000955200 · Cited by 450
Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
Hui, D. Y., Innerarity, T. L., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69254-9 · Cited by 383
Self-citationJi, Z. S., Brecht, W. J., Miranda, R. D., Hussain, M. M., Innerarity, T. L., & Mahley, R. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82186-x · Cited by 305
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Weisgraber, K. H., Rall, S. C., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35898-2 · Cited by 240
The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2
Stockinger, W., Brandes, C., Fasching, D., Hermann, M., Gotthardt, M., Herz, J., Schneider, W. J., & Nimpf, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004119200 · Cited by 239
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44181-0 · Cited by 220
Apolipoprotein E Inhibits Platelet Aggregation through the L-Arginine:Nitric Oxide Pathway
Riddell, D. R., Graham, A., & Owen, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.89 · Cited by 209
Identification and characterization of LRP8 (apoER2) in human blood platelets
Riddell, D. R., Vinogradov, D. V., Stannard, A. K., Chadwick, N., & Owen, J. S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34910-5 · Cited by 106
Research works printed but not linked: 36
- Mahley, 1988, Science, 240, 622, 10.1126/science.3283935 · DOI · Paper page
- Zhang, 1994, J. Clin. Invest., 94, 937, 10.1172/JCI117460 · DOI · Paper page
- Shimano, 1995, J. Clin. Invest., 95, 469, 10.1172/JCI117687 · DOI · Paper page
- Swertfeger, 2001, Front. Biosci., 6, d526, 10.2741/Swertfeg · DOI · Paper page
- Ishigami, 1998, J. Biol. Chem., 273, 20156, 10.1074/jbc.273.32.20156 · DOI · Paper page
- Ishigami, 2000, Arterioscler. Thromb. Vasc. Biol., 20, 1020, 10.1161/01.ATV.20.4.1020 · DOI · Paper page
- Yamamoto, 1996, Curr. Opin. Lipidol., 7, 298, 10.1097/00041433-199610000-00007 · DOI · Paper page
- Schneider, 1997, Curr. Opin. Lipidol., 8, 315, 10.1097/00041433-199710000-00011 · DOI · Paper page
- Tensen, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 4816, 10.1073/pnas.91.11.4816 · DOI · Paper page
- Trommsdorff, 1998, J. Biol. Chem., 273, 33556, 10.1074/jbc.273.50.33556 · DOI · Paper page
- Wehrli, 2000, Nature, 407, 527, 10.1038/35035110 · DOI · Paper page
- Tamai, 2000, Nature, 407, 530, 10.1038/35035117 · DOI · Paper page
- Pinson, 2000, Nature, 407, 535, 10.1038/35035124 · DOI · Paper page
- Couchman, 1996, J. Cell. Biochem., 61, 578, 10.1002/(SICI)1097-4644(19960616)61:4<578::AID-JCB11>3.0.CO;2-C · doi:10.1002/(sici)1097-4644(19960616)61:4<578::aid-jcb11>3.0.co;2-c
- Koyama, 1998, Circ. Res., 83, 305, 10.1161/01.RES.83.3.305 · DOI · Paper page
- Hirose, 2001, J. Biol. Chem., 276, 5228, 10.1074/jbc.M007542200 · DOI · Paper page
- Yla-Herttuala, 1996, Curr. Opin. Lipidol., 7, 292, 10.1097/00041433-199610000-00006 · doi:10.1097/00041433-199610000-00006
- Cardin, 1984, 5, 141
- Weisgraber, 1978, J. Biol. Chem., 253, 9053, 10.1016/S0021-9258(17)34284-9 · DOI · Paper page
- Mimura, 1995, Biol. Pharm. Bull., 18, 1203, 10.1248/bpb.18.1203 · doi:10.1248/bpb.18.1203
- Law, 1996, J. Clin. Invest., 98, 1897, 10.1172/JCI118991 · DOI · Paper page
- Cardin, 1986, Biochem. Biophys. Res. Commun., 134, 783, 10.1016/S0006-291X(86)80489-2 · DOI
- Pitas, 1980, J. Biol. Chem., 255, 5454, 10.1016/S0021-9258(19)70808-4 · DOI · Paper page
- Dyer, 1991, J. Biol. Chem., 266, 15009, 10.1016/S0021-9258(18)98578-9 · DOI · Paper page
- Mahley, 1979, Biochim. Biophys. Acta, 575, 81, 10.1016/0005-2760(79)90133-4 · DOI
- Hui, 1984, J. Biol. Chem., 259, 860, 10.1016/S0021-9258(17)43536-8 · DOI · Paper page
- Dyer, 1991, J. Biol. Chem., 266, 22803, 10.1016/S0021-9258(18)54425-2 · DOI · Paper page
- Obunike, 2000, Arterioscler. Thromb. Vasc. Biol., 20, 111, 10.1161/01.ATV.20.1.111 · DOI · Paper page
- Paka, 1999, J. Biol. Chem., 274, 36403, 10.1074/jbc.274.51.36403 · DOI
- Paka, 1999, J. Biol. Chem., 274, 4816, 10.1074/jbc.274.8.4816 · DOI · Paper page
- Iozzo, 1997, J. Biol. Chem., 272, 5219, 10.1074/jbc.272.8.5219 · DOI · Paper page
- Weiser, 1996, Matrix Biol., 15, 331, 10.1016/S0945-053X(96)90136-5 · DOI
- Trommsdorff, 1999, Cell, 97, 689, 10.1016/S0092-8674(00)80782-5 · DOI · Paper page
- Dyer, 1988, J. Biol. Chem., 263, 10965, 10.1016/S0021-9258(18)38064-5 · DOI
- Zerbinatti, 1999, Biol. Reprod., 61, 665, 10.1095/biolreprod61.3.665 · DOI
- Zhu, 2000, Am. J. Pathol., 157, 1839, 10.1016/S0002-9440(10)64823-7 · DOI
Cited by
Boucher, P., Liu, P., Gotthardt, M., Hiesberger, T., Anderson, R. G. W., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200428200 · Cited by 188
Wang, D., El-Amouri, S. S., Dai, M., Kuan, C.-Y., Hui, D. Y., Brady, R. O., & Pan, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222742110 · Cited by 159
“Several synthetic oligopeptides derived from this regionmimic certain aspects of receptor binding or apoE function in vitro and in vivo (22, 23).”
BackgroundSelf-citationAstroglial Regulation of Apolipoprotein E Expression in Neuronal Cells
Harris, F. M., Tesseur, I., Brecht, W. J., Xu, Q., Mullendorff, K., Chang, S., Wyss-Coray, T., Mahley, R. W., & Huang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309475200 · Cited by 135
Two-step Mechanism of Binding of Apolipoprotein E to Heparin
Futamura, M., Dhanasekaran, P., Handa, T., Phillips, M. C., Lund-Katz, S., & Saito, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411719200 · Cited by 91
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
Saito, H., Dhanasekaran, P., Nguyen, D., Baldwin, F., Weisgraber, K. H., Wehrli, S., Phillips, M. C., & Lund-Katz, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213207200 · Cited by 90
Metadata
- Authors
- Swertfeger, D. K., & Hui, D. Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 276
- Issue
- 27
- Pages
- 25043-25048
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2017397275
- Cited by
- 59
- References
- 11
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7204 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.